Hasan Jafri serves as Executive at Aridis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Hasan Jafri has executed 4 insider transactions totaling $21.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 5, 2023 involved exercising options for 10,000 shares valued at $0.
Hasan Jafri currently holds 15,100 shares of Aridis Pharmaceuticals, Inc. (ARDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hasan Jafri has been a net buyer of ARDS stock. They have purchased $21.1K and sold $0 worth of shares.
Hasan Jafri's most recent insider trade was on Jun 5, 2023, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.97 |
| Discretionary |
| Sep 7, 2021 | ARDS | $8.3K | Purchase | 1,991 | $4.15 | Discretionary |
| Sep 3, 2021 | ARDS | $12.5K | Purchase | 3,009 | $4.15 | Discretionary |